cp094 has been researched along with deferiprone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (84.21) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| el-Jammal, A; Howell, PL; Li, N; Templeton, DM; Turner, MA | 1 |
| Dobbin, PS; Hall, AD; Hider, RC; Porter, JB; Sarpong, P; Taylor, PD; van der Helm, D; Xiao, G | 1 |
| Dekhordi, LS; Hider, RC; Jin, Y; Khodr, H; Liu, Z; Rai, BL | 1 |
| Hider, RC; Khodr, HH; Liu, DY; Liu, ZD; Lu, SL | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Dehkordi, LS; Hider, RC; Liu, ZD | 1 |
| Fakih, S; Francis, PT; Gaeta, A; Hider, RC; Kong, XL; Molina-Holgado, F; Salvage, S; Williams, RJ | 1 |
| Crichton, RR; Florence, A; Peters, TJ; Ward, RJ | 1 |
| Bergeron, RJ; Creary, EA; Luchetta, G; Peter, HH; Streiff, RR; Wiegand, J | 1 |
| Grady, RW; Hershko, C; Hider, RC; Link, G; Peter, HH; Zevin, S | 1 |
| Caisová, D; Eybl, V; Kontoghiorghes, GJ; Koutenský, J | 1 |
| Brissot, P; Chenoufi, N; Cillard, J; Hubert, N; Lescoat, G; Loréal, O; Morel, I; Pasdeloup, N | 1 |
| Choudhury, R; Singh, S | 1 |
| Olivieri, NF; Parkes, JG; Randell, EW; Templeton, DM | 1 |
| Boelaert, J; Papavassiliou, P; Soteriadou, K; Voyiatzaki, C | 1 |
| Hershko, C; Link, G; Pinson, A | 1 |
| Boelaert, JR; Crichton, RR; de Locht, M; Schneider, YJ; Van Cutsem, J | 1 |
| Allen, DD; Fredenburg, AM; Sethi, RK; Yokel, RA | 1 |
| Berthon, G; Biron, F; Desroches, S | 1 |
19 other study(ies) available for cp094 and deferiprone
| Article | Year |
|---|---|
Copper complexation by 3-hydroxypyridin-4-one iron chelators: structural and iron competition studies.
Topics: Antithyroid Agents; Copper; Deferiprone; Iron Chelating Agents; Ligands; Potentiometry; Pyridones; Spectrophotometry | 1994 |
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
Topics: Administration, Oral; Animals; Crystallography; Deferoxamine; Horses; Humans; Iron; Iron Chelating Agents; Liver; Mice; Pyridones; Rats; Stereoisomerism; Structure-Activity Relationship | 1993 |
Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
Topics: Animals; Bile; Ferritins; Iron; Iron Chelating Agents; Male; Molecular Conformation; Pyridones; Rats; Rats, Inbred F344; Solutions; Structure-Activity Relationship | 1998 |
Synthesis, physicochemical characterization, and biological evaluation of 2-(1'-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe(3+) values.
Topics: Animals; Bile; Ferritins; Hydrogen-Ion Concentration; Iron; Iron Chelating Agents; Ligands; Potentiometry; Pyridines; Rats; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 1999 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Basic 3-hydroxypyridin-4-ones: potential antimalarial agents.
Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Iron; Iron Chelating Agents; Iron Overload; Male; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridones; Rats; Rats, Wistar; Structure-Activity Relationship | 2008 |
Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Death; Cells, Cultured; Humans; Hydrophobic and Hydrophilic Interactions; Iron Chelating Agents; Mice; Molecular Probes; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Pyrones; Structure-Activity Relationship | 2011 |
Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat.
Topics: Animals; Brain; Deferiprone; Deferoxamine; Disease Models, Animal; Ferrous Compounds; Heart; Hemochromatosis; Iron; Iron Chelating Agents; Liver; Male; Metallocenes; Organometallic Compounds; Pyridones; Rats; Rats, Wistar; Spleen; Subcellular Fractions | 1992 |
A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine.
Topics: Animals; Bile; Cebus; Deferiprone; Deferoxamine; Feces; Iron; Iron Chelating Agents; Kinetics; Male; Pyridones; Rats; Rats, Inbred Strains | 1992 |
Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
Topics: Animals; Deferiprone; Feces; Female; Iron; Iron Chelating Agents; Iron Radioisotopes; Liver; Mononuclear Phagocyte System; Pyridones; Rats; Rats, Inbred Strains | 1992 |
Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.
Topics: Animals; Cadmium; Carbon Tetrachloride; Deferiprone; Glutathione; In Vitro Techniques; Indium; Iron; Iron Chelating Agents; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Pyridones | 1991 |
Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cells, Cultured; Deferiprone; Extracellular Space; Humans; Iron; Iron Chelating Agents; Iron Radioisotopes; L-Lactate Dehydrogenase; Liver; Male; Malondialdehyde; Microscopy, Electron; Pyridones; Rats; Rats, Sprague-Dawley | 1995 |
Effect of iron overload on the metabolism and urinary recovery of 3-hydroxypyridin-4-one chelating agents in the rat.
Topics: Animals; Deferiprone; Drug Overdose; Iron; Iron Chelating Agents; Male; Pyridones; Rats; Rats, Wistar | 1995 |
Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
Topics: Biological Transport; Carcinoma, Hepatocellular; Cell Death; Deferiprone; Deferoxamine; Diffusion; Ferric Compounds; Humans; Iron; Iron Chelating Agents; Iron Radioisotopes; Kinetics; Liver; Liver Neoplasms; Nitrilotriacetic Acid; Pyridones; Quaternary Ammonium Compounds; Transferrin; Tumor Cells, Cultured | 1995 |
Effect of iron chelation on the in-vitro growth of Leishmania promastigotes.
Topics: Animals; Deferiprone; Deferoxamine; DNA; Electrophoresis, Polyacrylamide Gel; Immunoblotting; Iodine Radioisotopes; Iron Chelating Agents; Leishmania infantum; Leishmania major; Pyridones; Transferrin | 1995 |
Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells.
Topics: 5'-Nucleotidase; Administration, Oral; Animals; beta-N-Acetylhexosaminidases; Cells, Cultured; Deferiprone; Deferoxamine; Heart; Iron; Iron Chelating Agents; Lysosomes; Myocardium; Pyridones; Rats; Sarcolemma; Sodium-Potassium-Exchanging ATPase; Sulfhydryl Compounds | 1994 |
Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect.
Topics: Animals; Deferiprone; Deferoxamine; Guinea Pigs; Iron; Iron Chelating Agents; Male; Mucormycosis; Pyridones; Rhizopus; Transferrin | 1994 |
The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethly-, 1,2 diethyl-, and 1-[ethan-1'ol]-2-methyl-3-hydroxypyridin-4-one in the rat.
Topics: Animals; Blood-Brain Barrier; Cerebral Ventricles; Chelating Agents; Deferiprone; Frontal Lobe; Iron Chelating Agents; Male; Microdialysis; Pyridones; Rats; Rats, Sprague-Dawley; Sodium Cyanide | 1996 |
Aluminum speciation studies in biological fluids. Part 5. A quantitative investigation of A1(III) complex equilibria with desferrioxamine, 2,3-dihydroxybenzoic acid, Tiron, CP20 (L1), and CP94 under physiological conditions, and computer-aided assessment
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Aluminum; Animals; Body Fluids; Chelating Agents; Computer Simulation; Deferiprone; Deferoxamine; Humans; Hydroxybenzoates; Indicators and Reagents; Inflammation; Iron Chelating Agents; Ligands; Pyridones; Rabbits; Rats; Reproducibility of Results | 1999 |